Skip to content
healthcare.dev

Teriflunomide

NDC 59651-055, Teriflunomide, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-055
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209638
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-055 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERIFLUNOMIDE14 mg/1

Pharmacologic classes

Dihydroorotate Dehydrogenase Inhibitors [MoA]; Pyrimidine Synthesis Inhibitor [EPC]

Package NDCNDC-11Package
59651-055-28596510055282 BLISTER PACK in 1 CARTON (59651-055-28) / 14 TABLET in 1 BLISTER PACK
59651-055-305965100553030 TABLET in 1 BOTTLE (59651-055-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2fd80242-c607-4c50-b497-8259abb4a2f8
  • NADAC price for package 59651005530

    GET /v1/drugs/nadac/59651005530

Use it

Look up 59651-055 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-055 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-055. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.